logo
#

Latest news with #EMRs

From Pixels to Precision: AI's Emerging Role in Personalized Cancer Treatment
From Pixels to Precision: AI's Emerging Role in Personalized Cancer Treatment

Time of India

time23-04-2025

  • Health
  • Time of India

From Pixels to Precision: AI's Emerging Role in Personalized Cancer Treatment

New Delhi: Artificial intelligence (AI) is steadily emerging as a vital co-pilot in the fight against cancer, offering new possibilities in diagnosis, treatment planning, and clinical efficiency. In an exclusive interaction with journalist Rashmi Mabiyan Kaur, Dr. Nikhil S Ghadyalpatil , Director of Medical Oncology at Apollo Cancer Centre , Hyderabad, shared how AI is being seamlessly integrated into their clinical workflow—not to replace doctors, but to enhance their decision-making capabilities and streamline the delivery of personalized cancer care . As per Dr Ghadyalpatil, the AI system acts as a digital assistant that scans new patient data, flags urgent findings, and suggests evidence-based treatments. It's currently being integrated across imaging, pathology, and electronic medical records (EMRs), with a particular focus on rare cancers and complex genomic profiles. 'The real value of AI lies in shrinking the time between data generation and clinical decision-making,' he noted. 'Often, treatment options go beyond textbook guidelines, and AI helps ensure no actionable mutation or imaging clue is missed.' AI applications are already showing promise. In radiology, genomics, and pathology, the team is exploring ways to use AI to correlate MRI scans with genomic data or pathology slides to determine genetic mutations more rapidly and affordably. AI is also being tested to reduce human error in oncology pharmacology prescriptions—errors that, while rare, can have serious consequences. Building this AI ecosystem has not been without hurdles. Standardizing data across disparate formats—particularly handwritten clinical notes and non-standard pathology images—has been time-consuming. Another challenge? Earning clinician trust. 'AI success is less about algorithms and more about clinician trust,' Dr. Ghadyalpatil explained. 'If the tools are transparent and support clinical judgment, they will be embraced.' The hospital's strategy emphasizes smart scaling: start narrow, validate rigorously, and adapt to local needs. 'Don't blindly adopt Western models,' he cautioned. 'India is different. AI tools must be trained and validated on Indian data to offer meaningful insights.' Their current focus areas include AI-driven radiomics in early-stage lung cancer, predictive models combining PET/CT scans with biomarkers in breast and lung cancer, and structured dashboards that summarize clinical notes to detect early warning signs of complications like neutropenia or sepsis. He also stressed the importance of addressing systemic challenges: data interoperability, clinician training, lack of local validation, and limited infrastructure in smaller cities. 'Less than 20% of Indian cancer centers have structured digital archives,' he noted. 'That has to change.' Looking forward, Dr. Ghadyalpatil sees immense potential for AI in early cancer detection and rural screening—through tools like smartphone cytology and low-cost thermal imaging. 'If we build the right digital infrastructure, train our teams, and choose our pilots wisely,' he said, 'AI can become a silent, steady partner in delivering truly personalized cancer care—across all corners of India.' He envisions India developing its own treatment insights through privacy-preserving AI trained on data from hundreds of hospitals.

Abundant Health Acquisition and Praia Health partner for digital care
Abundant Health Acquisition and Praia Health partner for digital care

Yahoo

time17-04-2025

  • Business
  • Yahoo

Abundant Health Acquisition and Praia Health partner for digital care

Abundant Health Acquisition (aha!) and Praia Health have formed a strategic partnership focusing on healthcare organisations' engagement with consumers digitally, from initial discovery through to extended retention. The partnership combines aha!'s Health Experience Platform (HXP), which facilitates engagement and acquisition on public-facing websites via open scheduling, intelligent provider search, and tailored content, with Praia Health's platform, which strengthens identity-powered experiences on mobile apps and web portals. aha! and Praia Health aim to deliver a solution to healthcare systems that is integrated and scalable. This is expected to minimise fragmentation and combines digital touchpoints into a cohesive experience. The partnership also promises to remove friction and create a cohesive journey for healthcare consumers. aha! CEO Paul Dain said: 'This partnership is about delivering the connected, intelligent experience that healthcare consumers expect, and health systems need to remain competitive. 'Together, we're bringing cohesion to a historically fragmented journey.' The market will benefit from this partnership through a unified system that covers digital access, marketing, and care navigation. The solution is designed to integrate into existing infrastructure, such as Sitecore, electronic medical records (EMRs), and Microsoft Entra, and has already been deployed with health systems to manage patient interactions. The partnership will concentrate on aligning go-to-market efforts, jointly developing solutions, and working together on deployments with health systems. These efforts are focused on modernising digital access, enhancing conversion rates, and driving extended engagement. Praia Health CEO Justin Dearborn said: 'By combining Praia's personalisation engine with aha!'s front-door capabilities, we're giving health systems the power to anticipate and orchestrate each consumer's path to care on their terms.' Earlier this year, US-based care access platform Kyruus Health collaborated with aha! to merge their technologies to enhance patient access and engagement. "Abundant Health Acquisition and Praia Health partner for digital care" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio

Saudi German Hospital Al Jamea District achieves prestigious HIMSS Stage 6 Certification
Saudi German Hospital Al Jamea District achieves prestigious HIMSS Stage 6 Certification

Mid East Info

time10-02-2025

  • Health
  • Mid East Info

Saudi German Hospital Al Jamea District achieves prestigious HIMSS Stage 6 Certification

Saudi German Hospital – Hai Aljamea (HAJ) has been awarded the renowned HIMSS Stage 6 certification, a globally recognised accreditation for excellence in digital healthcare transformation. This achievement demonstrates the hospital's dedication to integrating cutting-edge healthcare technologies to improve patient care, safety, and operational efficiency. The HIMSS Stage 6 certification is part of the Electronic Medical Record Adoption Model (EMRAM), which assesses healthcare organizations based on their effective use of electronic medical records (EMRs) to enhance clinical workflows and patient outcomes. By obtaining this accreditation, SGH-HAJ secured a leading position in digital healthcare, further reinforcing its brand credibility and trust within the industry. Makarem Sobhi Batterjee, Vice Chairman of Saudi German Health, stated: 'Our commitment to continuous innovation in healthcare services is demonstrated by our achievement of HIMSS Stage 6 certification. This milestone reflects our dedication to implementing innovative solutions that ensure patient safety, enhance workflows, and elevate the overall standard of care, further solidifying SGH-HAJ's position as a leader in digital healthcare.' The establishment of SGH-HAJ followed modern medical technology and international standards, ensuring high-quality patient care. This milestone marks a new chapter in Saudi German Health's legacy of over thirty years of success in the healthcare industry.

Saudi German Hospital Al Jamea District achieves prestigious HIMSS Stage 6 Certification
Saudi German Hospital Al Jamea District achieves prestigious HIMSS Stage 6 Certification

Zawya

time10-02-2025

  • Health
  • Zawya

Saudi German Hospital Al Jamea District achieves prestigious HIMSS Stage 6 Certification

KSA - Saudi German Hospital – Hai Aljamea (HAJ) has been awarded the renowned HIMSS Stage 6 certification, a globally recognised accreditation for excellence in digital healthcare transformation. This achievement demonstrates the hospital's dedication to integrating cutting-edge healthcare technologies to improve patient care, safety, and operational efficiency. The HIMSS Stage 6 certification is part of the Electronic Medical Record Adoption Model (EMRAM), which assesses healthcare organizations based on their effective use of electronic medical records (EMRs) to enhance clinical workflows and patient outcomes. By obtaining this accreditation, SGH-HAJ secured a leading position in digital healthcare, further reinforcing its brand credibility and trust within the industry. Makarem Sobhi Batterjee, Vice Chairman of Saudi German Health, stated: 'Our commitment to continuous innovation in healthcare services is demonstrated by our achievement of HIMSS Stage 6 certification. This milestone reflects our dedication to implementing innovative solutions that ensure patient safety, enhance workflows, and elevate the overall standard of care, further solidifying SGH-HAJ's position as a leader in digital healthcare." The establishment of SGH-HAJ followed modern medical technology and international standards, ensuring high-quality patient care. This milestone marks a new chapter in Saudi German Health's legacy of over thirty years of success in the healthcare industry. -Ends- For further information, please contact: Orient Planet Group (OPG) Email: media@ Website:

Exclusive: Kode Health raises $27M for on-demand medical coders
Exclusive: Kode Health raises $27M for on-demand medical coders

Axios

time05-02-2025

  • Business
  • Axios

Exclusive: Kode Health raises $27M for on-demand medical coders

Kode Health, an on-demand medical coding platform, raised a $27 million Series B, co-founder Brad Sawdon tells Axios exclusively. Why it matters: Health-care administrative costs, which include coding expenses, now account for up to 30% of total U.S. health care expenditures. Zoom in: Noro-Moseley led, joined by Mercury, FCA Venture Partners, Epsilon Innovation Fund and 111 West Capital. Kode is currently generating "well over" $10 million in revenue, and "we try to remain at break even or profitable, when we can," Sawdon says. How it works: Kode has a network of more than 5,500 medical coders that work within hospital clients' system, with access to EMRs to extract patient data, compliant with HIPAA protocols. Kode, based in Holland, Michigan, currently has roughly 40 hospitals and health systems signed up. "We help these systems with improvements to not only the cost savings aspect of all the administrative dollars spent that go into coding, but also smoothing out the balance sheet component of it," Sawdon says. What's next: Capital will go towards further development of AI-driven tools helping hospitals and providers to better respond to workflow fluctuations. Sawdon says he does not anticipate pursuing another funding round at this time. What they're saying:"This is a solution that can drive real near-term ROI, with immediate increases in revenue and collections, along with decreases in cost," says Spence McClelland, partner at Noro-Moseley Partners.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store